{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:58:41Z","timestamp":1790175521605,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"The Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS037167"],"award-info":[{"award-number":["R01NS037167"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA141668"],"award-info":[{"award-number":["R01CA141668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50NS071674"],"award-info":[{"award-number":["P50NS071674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Barnes-Jewish Hospital Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Federal Ministry of Education, Science, Research, and Technology"},{"name":"German National Genome Network","award":["01GS08134"],"award-info":[{"award-number":["01GS08134"]}]},{"name":"German Federal Ministry of Education and Research","award":["01GR0468"],"award-info":[{"award-number":["01GR0468"]}]},{"DOI":"10.13039\/501100001656","name":"Helmholtz Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French National Agency of Research","award":["ANR-08-MNP-012"],"award-info":[{"award-number":["ANR-08-MNP-012"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083948\/Z\/07\/Z"],"award-info":[{"award-number":["083948\/Z\/07\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson's UK","award":["8047"],"award-info":[{"award-number":["8047"]}]},{"name":"Parkinson's UK","award":["J-0804"],"award-info":[{"award-number":["J-0804"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0700943"],"award-info":[{"award-number":["G0700943"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1100643"],"award-info":[{"award-number":["G1100643"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurobiolaging.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:37:37Z","timestamp":1469777857000},"page":"222.e1-222.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease"],"prefix":"10.1016","volume":"48","author":[{"given":"S.J.","family":"Lubbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Escott-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Heutink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Demenais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.T.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Newton-Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A\u00a0method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","article-title":"Parkinson's disease and cancer risk: a systematic review and meta-analysis","volume":"21","author":"Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.parkreldis.2009.11.005","article-title":"Cancer risk in association with Parkinson disease: a population-based study","volume":"16","author":"Becker","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"Catal\u00e1-L\u00f3pez","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib5","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1073\/pnas.0931262100","article-title":"Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27","volume":"100","author":"Cesari","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gr.092619.109","article-title":"Identification of deleterious mutations within three human genomes","volume":"19","author":"Chun","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/mds.20123","article-title":"Tumor diagnosis preceding Parkinson's disease: a case-control study","volume":"19","author":"D'Amelio","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib8","doi-asserted-by":"crossref","first-page":"e1001025","DOI":"10.1371\/journal.pcbi.1001025","article-title":"Identifying a high fraction of the human genome to be under selective constraint using GERP++","volume":"6","author":"Davydov","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrc3150","article-title":"Parkinson's disease and cancer: two wars, one front","volume":"11","author":"Devine","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib10","doi-asserted-by":"crossref","first-page":"1512.e5","DOI":"10.1016\/j.neurobiolaging.2013.12.020","article-title":"Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease","volume":"35","author":"Dong","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.21882","article-title":"Pigmentation in the human brain and risk of Parkinson's disease","volume":"67","author":"Double","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001648-200203000-00010","article-title":"Nonfatal cancer preceding Parkinson's disease: a case-control study","volume":"13","author":"Elbaz","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/mds.20401","article-title":"Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study","volume":"20","author":"Elbaz","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature11690","article-title":"Analysis of 6515 exomes reveals the recent origin of most human protein-coding variants","volume":"493","author":"Fu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1212\/WNL.0b013e3181bd13a1","article-title":"Family history of melanoma and Parkinson disease risk","volume":"73","author":"Gao","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.21535","article-title":"Genetic determinants of hair color and Parkinson's disease risk","volume":"65","author":"Gao","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib18","doi-asserted-by":"crossref","first-page":"545.e9","DOI":"10.1016\/j.neurobiolaging.2014.07.038","article-title":"Mutation analysis of patients with neurodegenerative disorders using NeuroX array","volume":"36","author":"Ghani","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib19","series-title":"Developmental Biology","volume":"6th ed","author":"Gilbert","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib20","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.febslet.2006.03.018","article-title":"\u03b1-Synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease","volume":"580","author":"Hasegawa","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mehy.2008.10.011","article-title":"Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies","volume":"72","author":"Herrero Hern\u00e1ndez","year":"2009","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.21688","article-title":"Pigmentation as a clue to understanding Parkinson's disease and melanoma","volume":"65","author":"Herrero Hern\u00e1ndez","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib24","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/archneurol.2012.2261","article-title":"Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study","volume":"69","author":"Kareus","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2005.02.010","article-title":"DJ-1, a novel regulator of the tumor suppressor PTEN","volume":"7","author":"Kim","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib26","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1093\/hmg\/ddv376","article-title":"A\u00a0systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease","volume":"24","author":"Kun-Rodrigues","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib28","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1021\/bi201173d","article-title":"Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant","volume":"50","author":"Liu","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib29","first-page":"259","article-title":"Recent advances in Parkinson's disease genetics","volume":"261","author":"Lubbe","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.24527","article-title":"Is the MC1R variant p.R160W associated with Parkinson's?","volume":"79","author":"Lubbe","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib31","doi-asserted-by":"crossref","first-page":"e10481","DOI":"10.1371\/journal.pone.0010481","article-title":"Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma","volume":"5","author":"Matsuo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib33","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"Parkinson's disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/1055-9965.EPI-11-0905","article-title":"No association between Parkinson disease alleles and the risk of melanoma","volume":"21","author":"Meng","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib35","first-page":"5449","article-title":"Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma","volume":"51","author":"Millikin","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj20030017","article-title":"Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines","volume":"373","author":"Nair","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib37","doi-asserted-by":"crossref","first-page":"1605.e7","DOI":"10.1016\/j.neurobiolaging.2014.07.028","article-title":"NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases","volume":"36","author":"Nalls","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","article-title":"Atypical cancer pattern in patients with Parkinson's disease","volume":"369","author":"Olsen","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ede.0000229445.90471.5e","article-title":"Malignant melanoma and other types of cancer preceding Parkinson disease","volume":"17","author":"Olsen","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib41","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.ejca.2014.06.018","article-title":"Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study","volume":"50","author":"Ong","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib42","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/ijc.25912","article-title":"The association between Parkinson's disease and melanoma","volume":"128","author":"Pan","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib43","series-title":"Meta-analysis, Decision Analysis and Cost-effectiveness Analysis","author":"Petitti","year":"1994"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1101\/gr.097857.109","article-title":"Detection of nonneutral substitution rates on mammalian phylogenies","volume":"20","author":"Pollard","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib47","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajhg.2013.09.008","article-title":"ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19","volume":"93","author":"Takahashi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ana.24373","article-title":"The MC1R melanoma risk variant p.R160W is associated with Parkinson disease","volume":"77","author":"Tell-Marti","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.1219240","article-title":"Evolution and functional impact of rare coding variation from deep sequencing of human exomes","volume":"337","author":"Tennessen","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib50","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1038\/cddis.2012.194","article-title":"Dopamine protects neurons against glutamate-induced excitotoxicity","volume":"4","author":"Vaarmann","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib51","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/aje\/kwt232","article-title":"Parkinson's disease and cancer: a register-based family study","volume":"179","author":"Wirdefeldt","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajhg.2011.05.029","article-title":"Rare-variant association testing for sequencing data with the sequence kernel association test","volume":"89","author":"Wu","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(96)00308-7","article-title":"Tyrosinase mRNA is expressed in human substantia nigra","volume":"45","author":"Xu","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","article-title":"Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics","volume":"26","author":"Zecca","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.07.013_bib56","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1073\/pnas.1322563111","article-title":"Searching for missing heritability: designing rare variant association studies","volume":"111","author":"Zuk","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016301506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016301506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T17:32:38Z","timestamp":1655659958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016301506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":56,"alternative-id":["S0197458016301506"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.07.013","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}